Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 19.64
-0.14 (-0.71%)
Jul 6, 2026, 5:00 PM CET
Celon Pharma Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 108.32 | -79.36 | -34.45 | -28.12 | -39.28 | -11.61 |
Depreciation & Amortization | -2.13 | - | 51.15 | 48.95 | 42.43 | 39.38 |
Other Amortization | - | - | 0.71 | 1.06 | 1.67 | 1.96 |
Loss (Gain) From Sale of Assets | 0.28 | - | -7.64 | -10.95 | -3.48 | -0.13 |
Loss (Gain) From Sale of Investments | 1.84 | - | -9.74 | - | - | - |
Other Operating Activities | -70.21 | 103.22 | 0.16 | 11.86 | 2.56 | 0.28 |
Change in Accounts Receivable | -5.82 | - | -1.64 | -12.54 | -6.46 | 13.24 |
Change in Inventory | 1.28 | - | -3.77 | 11.98 | -15.01 | 6.38 |
Change in Other Net Operating Assets | -0.95 | - | -6.12 | -30.55 | 12.87 | -5.56 |
Operating Cash Flow | 30.47 | 23.85 | -11.34 | -8.31 | -4.7 | 43.95 |
Operating Cash Flow Growth | - | - | - | - | - | -38.73% |
Capital Expenditures | -10.65 | - | -22.79 | -32.81 | -33.91 | -41.35 |
Sale of Property, Plant & Equipment | -0.1 | - | 0.68 | 1.24 | 0.59 | 0.17 |
Cash Acquisitions | - | - | -16.36 | - | - | - |
Investment in Securities | -20 | - | 40 | 9.5 | - | -79.87 |
Other Investing Activities | -12.62 | -21.63 | 0.06 | 0.43 | 1.85 | - |
Investing Cash Flow | -43.37 | -21.63 | -7.49 | -21.64 | -31.47 | -121.05 |
Short-Term Debt Issued | - | - | 1.53 | 12.75 | - | - |
Total Debt Issued | 7.58 | - | 1.53 | 12.75 | - | - |
Short-Term Debt Repaid | - | - | -12.75 | - | - | -12.84 |
Long-Term Debt Repaid | - | - | -9.69 | -26.13 | -12.43 | -4.8 |
Total Debt Repaid | -0.07 | - | -22.44 | -26.13 | -12.43 | -17.64 |
Net Debt Issued (Repaid) | 7.5 | - | -20.91 | -13.37 | -12.43 | -17.64 |
Issuance of Common Stock | - | - | 40.51 | 0 | 0 | 216 |
Common Dividends Paid | - | - | -4.09 | -4.6 | -14.8 | -3.15 |
Other Financing Activities | -9.63 | -9.76 | -2.19 | -2.62 | -1.5 | -14.3 |
Financing Cash Flow | -2.13 | -9.76 | 13.32 | -20.59 | -28.72 | 180.91 |
Miscellaneous Cash Flow Adjustments | 0 | - | -0 | - | - | - |
Net Cash Flow | -15.02 | -7.54 | -5.51 | -50.54 | -64.89 | 103.82 |
Free Cash Flow | 19.83 | 23.85 | -34.13 | -41.13 | -38.61 | 2.6 |
Free Cash Flow Margin | 7.73% | 9.76% | -16.61% | -19.16% | -19.91% | 1.33% |
Free Cash Flow Per Share | 0.37 | 0.45 | -0.65 | -0.81 | -0.76 | 0.06 |
Cash Interest Paid | - | - | 2.19 | 2.62 | 1.5 | 0.94 |
Cash Income Tax Paid | - | - | -1.07 | -0.97 | -0.52 | - |
Levered Free Cash Flow | -15.75 | - | -23.92 | -34.98 | -18.83 | -1.33 |
Unlevered Free Cash Flow | -15.72 | - | -22.38 | -33.32 | -17.79 | -0.36 |
Change in Working Capital | -5.49 | - | -11.53 | -31.11 | -8.6 | 14.07 |